(Q73821856)

English

Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanoma

scientific article published on 01 October 1997

In more languages
default for all languages
No label defined

No description defined

Statements

Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanoma (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit